Obagi Medical Products (OMPI) Says Condition & Enhance System Improves Results of Intense Pulsed Light Treatments

March 9, 2009 8:34 AM EDT

Obagi Medical Products, Inc. (Nasdaq: OMPI) announced today results from a new clinical study that showed that its Condition & Enhance System, when combined with Intense Pulsed Light treatments, provided greater improvement in overall facial appearance as well as increased patient satisfaction vs. IPL treatments with placebo.

At the conclusion of the study, physician ratings of overall improvement in facial appearance were significantly greater with the Condition & Enhance System + IPL as compared to IPL with placebo. 72% of Condition & Enhance + IPL patients achieved a 75% overall improvement in facial appearance vs. 19% using IPL with placebo. In addition, statistically significant benefits were seen in hyperpigmentation and skin laxity as well as improved levels of skin texture and fine lines and wrinkles. Similarly, the Condition & Enhance System was clinically proven to increase patient satisfaction. 83% of patients were either Satisfied or Very Satisfied with their overall facial appearance, as compared to 56% using IPL with placebo, and 94% were Satisfied or Very Satisfied with the treatment regimen. This data was presented at the March, 2009 American Academy of Dermatology Annual Meeting in San Francisco.

Participants in the observer-masked, randomized, placebo-controlled study ranged in age from 35-65 years and exhibited moderate to severe photodamage. Over the course of the 90 day trial, 35 participants were instructed to either use the Condition & Enhance System or a placebo-based regimen. Each participant received two IPL treatments.

Related Categories

Corporate News

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?